Results 51 to 60 of about 2,195 (154)

Cutis Verticis Gyrata Across the Diagnostic Spectrum: Two Cases Highlighting Challenges in Clinical Classification

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Cutis verticis gyrata (CVG) is an uncommon disorder characterized by cerebriform thickening of the scalp that may occur as a primary condition or secondary to a variety of systemic disorders. We report two patients with clinically distinct presentations of CVG illustrating the diagnostic challenges encountered during classification.
Sanket Bishokarma   +2 more
wiley   +1 more source

Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T‐Cell Therapy in TP53‐Deleted CLL: A Case Report

open access: yeseJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Cutaneous manifestations of chronic lymphocytic leukemia (CLL) are heterogeneous and may result from leukemic infiltration, secondary malignancies, infectious complications, or reactive inflammatory processes. Reactive angioendotheliomatosis (RAE) is a rare vascular proliferation that has only infrequently been reported in association with ...
Feras Alfraih   +4 more
wiley   +1 more source

Úlceras dolorosas en la cavidad oral como expresión de leucemia cutis Painful sores in the oral cavity as an expression of leukemia cutis

open access: yesRevista de la Asociación Odontológica Argentina, 2012
Resumen Objetivo: Presentar el caso de una paciente con leucemia cutis en cavidad oral, con úlceras dolorosas a partir de las cuales se le diagnosticó leucemia mieloide aguda (LMA).
Mariana Vidomlansky de la Vega   +5 more
doaj  

Leukemia cutis with lymphoglandular bodies: a clue to acute lymphoblastic leukemia cutis [PDF]

open access: yesDermatology Online Journal, 2015
Leukemia cutis describes cutaneous lesions produced by infiltrates of leukemic cells. It usually manifests contemporaneously with the initial diagnosis of systemic leukemia, but may also precede or follow systemic leukemia. Most cases are associated with acute myeloid leukemia. Adult B-cell lymphoblastic leukemia cutis is very rare. We report a 59-year-
Obiozor, Cynthia   +2 more
openaire   +4 more sources

Update on Approved Therapies for Dystrophic and Junctional Epidermolysis Bullosa

open access: yesPediatric Dermatology, Volume 43, Issue S2, Page 20-28, August 2026.
ABSTRACT Dystrophic epidermolysis bullosa (DEB) and junctional EB (JEB) are severe, bullous genodermatoses induced by mutations of genes encoding structural skin proteins that disrupt epidermal adhesion. Until recently, treatment was limited to symptomatic care. Since 2022, three therapies – birch triterpenes gel (Filsuvez), beremagene geperpavec‐svdt (
Alberto Pappalardo   +5 more
wiley   +1 more source

Acute Myeloid Leukemia With KAT6A::CREBBP Rearrangement: A Rare Entity With Potential Diagnostic Pitfalls

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Adam Lyle   +2 more
wiley   +1 more source

Aleukemic Monocytic Leukemia Cutis [PDF]

open access: yesMayo Clinic Proceedings, 1996
Aleukemic leukemia cutis is a rare condition in which leukemic cells invade the skin before they appear in peripheral blood or bone marrow specimens. Herein we describe a 67-year-old man who underwent assessment because of papules and nodules on his back and lower extremities.
M S, Daoud   +3 more
openaire   +2 more sources

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page e1472-e1474, October 2026.
Juan de Luque‐Fernández   +5 more
wiley   +1 more source

Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study

open access: yesThe Journal of Pathology: Clinical Research, Volume 12, Issue 2, March 2026.
Abstract Myeloid sarcoma (MS) is a tumorous extramedullary proliferation of blast or blast equivalent cells (e.g., promonocytes or promyelocytes). The most frequent cutaneous presentation is often referred to as leukemia cutis (LC). These lesions, especially without the clinical context of a known bone marrow disease, pose a differential diagnostic ...
Alex Jenei   +10 more
wiley   +1 more source

Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT We report a 69‐year‐old man diagnosed as myelodysplastic syndrome and administrated with azacitidine and selinexor treatment. Then he was revealed high fever and multiple tender erythematous papules involving his mouth, back, upper and lower extremities, which were diagnosed as Sweet's syndrome by skin biopsy.
Liya Ma   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy